Karagiannidis C, Bein T, Weber-Carstens S
ARDS und ECMO Zentrum, Lungenklinik Köln-Merheim, Kliniken der Stadt Köln gGmbH, Universität Witten/Herdecke, Ostmerheimer Straße 200, 51109, Köln, Deutschland.
Klinik für Anästhesie und operative Intensivmedizin, Universitätsklinikum Regensburg, Regensburg, Deutschland.
Med Klin Intensivmed Notfmed. 2019 Apr;114(3):207-213. doi: 10.1007/s00063-019-0533-3. Epub 2019 Feb 5.
The present work sheds light on the possibilities and limitations of modern extracorporeal membrane oxygenation (ECMO) therapy in the case of heart or lung failure. Since the number of applications of extracorporeal lung and heart/lung replacement procedures has increased dramatically in the last few years in severely ill patients, decision-making for a meaningful indication and in the course of a possible therapy target change has become particularly difficult, especially with regard to the complex situation in organ transplantation in Germany. An attempt is made to elucidate the dilemma between data from large controlled trials and epidemiological studies and the patients' individuality.
目前的研究揭示了现代体外膜肺氧合（ECMO）治疗在心肺衰竭病例中的可能性和局限性。由于过去几年中，重症患者体外肺和心肺替代程序的应用数量急剧增加，对于有意义的适应症的决策以及在可能的治疗目标改变过程中的决策变得尤为困难，特别是考虑到德国器官移植的复杂情况。本文试图阐明大型对照试验和流行病学研究数据与患者个体性之间的困境。
